A new study reveals that the popular diabetes and weight-loss drug Ozempic might hold the key to relieving chronic migraines, ...

Migraines are one of the world's most common neurological conditions, impacting nearly 15% of people globally. Despite this ...

Hope may be on the horizon, however, according to a new pilot study published on June 17 in Headache: The Journal of Head and ...

Ozempic-style drugs tied to more than 60 health benefits ... If confirmed, however, the findings could open up a new line of inquiry for migraine treatment, Braca said.

In a small trial of 31 people with chronic migraines who didn’t respond to other treatments, liraglutide slashed the number of days they experienced migraines by over half. Although the volunteers ...

A current weight-loss and diabetes drug has become a surprise candidate for migraine treatment, with a new pilot study ...

Migraines are a common ailment worldwide, affecting nearly 15% of the global population. At times, they can be debilitating enough to interfere with daily activities. Despite a multitude of treatment ...

New research finds that men taking a GLP-1 for their obesity or type 2 diabetes often experience a rise in testosterone levels.

Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...

A new study suggests that a medication in the same family as Ozempic could cut the number of days people suffer from migraines by more than half. A drug in the same family as Ozempic could unlock ...